Angioplasty with drug-eluting stents versus bypass grafting for treatment ofunprotected left main stem disease.

Medically treated patients with unprotected left main stem (LMS) coronary artery disease have a poor prognosis and early evidence suggests there is a strong survival benefit from surgical revascularization, especially in patients with left ventricular systolic dysfunction.